NEW YORK, July 11 (GenomeWeb News) - Shares in Stratagene were up 5.9 percent, or $.51, at $9.14 in late-afternoon trading after the company said it won a US patent for its FullVelocity technology.
The patent, No. 6,893,819, is entitled "Methods for Detection of a Nucleic Acid by Sequential Amplification." According to Stratagene, it covers "novel methods for the detection of infectious agents, cancer and genetic traits."
It is the fifth patent the company has won for the FullVelocity technology.
The technology described in the patent "can enhance FullVelocity and Taq-based chemistries by offering increased multiplexing capabilities at a potentially lower cost," Stratagene president and CEO Joseph Sorge said in a statement.